submit to the journals

Cardiovascular Risk Journal Articles, Videos And Insights

Cardiovascular Risk: FEATURED Articles

flipper_slider

Cardiovascular Risk: Latest Articles

Cardiovascular Risk: INSIGHTS

The touchENDOCRINOLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of endocrinology:

Insight
Lipodystrophy – an Insight into a Rare Condition with Severe Metabolic Consequences Katrina Mountfort, Senior Medical Writer, Touch Medical Media, UK
Matthew Goodwin, Group Director and Advisory Editor, Touch Medical Media, UK
-Insights into lipodystrophies, presented at the ECE congress, Barcelona, Spain, Monday 21 May 2018

Cardiovascular Risk: FEATURED VIDEOS

Editor's choice

We are pleased to introduce Abd Tahrani as the new Editor in Chief for European Endocrinology. In this interview Dr Tahrani discusses his research interests and his aims for the journal over the next year. FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING, SEPTEMBER 2016 COULD YOU TELL US A LITTLE ABOUT YOURSELF AND YOUR CAREER TO DATE? 00:19 - My name is Abd Tahrani. I’m a National Institute for Health Research Clinician Scientist at the University of Birmingham and an Honorary Consultant Physician in Diabetes and Endocrinology and Obesity at Heart of England NHS Foundation Trust. I’m also the lead for weight management research and diabetic neuropathy at Heart of England NHS Foundation Trust. My career started in the UK in the year 2000 when I did my general training, which was completed by obtaining MRCP(UK) in 2003. Then after that, I joined the specialty of Diabetes Endocrinology and Obesity and continued my training until I finished and obtained CCT in Diabetes and Endocrinology in 2012. During that time, I obtained a Master’s in Medical Sciences from Keele University and I also obtained my PhD at the University of Birmingham. Following that, I also obtained a special certification in Obesity Education and Prevention from the World Obesity Federation, and I was also awarded their National Fellowship. WHAT ARE YOUR MAIN RESEARCH INTERESTS? 01:26 – My main research is focussed on four main areas. The first area is the metabolic impact of sleep-related disorders, particularly in the fields of diabetes, obesity and vascular disease. My second main area is understanding the pathogenesis and developing new treatments for diabetes-related microvascular complications. My third area is developing obesity management, and that extends from lifestyle interventions to bariatric surgery. And finally, I have a major interest in the pharmacology of type 2 diabetes. WHAT DO YOU CONSIDER THE MOST EXCITING DEVELOPMENTS IN THE DIABETES FIELD OVER THE PAST YEAR? 02:09 - Over the past year, there have been several landmark studies published, particularly in relation to the cardiovascular outcome studies, including LEADER, EMPA-REG, and in this conference, we’ll hear more about SUSTAIN. And I think these studies have resulted in major developments in the way we treat patients with diabetes in terms of reducing their cardiovascular risk, as well as improving or reducing the risk of development of nephropathy. WHAT DO YOU CONSIDER THE GREATEST STRENGTH OF EUROPEAN ENDOCRINOLOGY? 02:45 - The greatest strength of European Endocrinology is that it has a very distinguished editorial pool that has leading investigators of international reputation and they are leaders in their field. It has also published very high-quality articles written by leaders in the field of diabetes and endocrinology and obesity. In addition, it’s open access format which allows the articles to be easily available at the time of publication to the research community and the public. WHAT ARE YOUR AIMS FOR THE JOURNAL OVER THE NEXT YEAR? 03:20 – Over the next year, I look forward to working with my colleagues at European Endocrinology. We will mainly focus on increasing the multimedia content and will work also with the Editorial Board to increase the variety of submissions which will be published in European Endocrinology.

Cardiovascular Risk: Latest Videos

Video List based on Category on Node Page

Latest Videos

We are pleased to introduce Abd Tahrani as the new Editor in Chief for European Endocrinology. In this interview Dr Tahrani discusses his research interests and his aims for the journal over the next year. FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING,...
Antonio Ceriello gives his opinion on how the results of the outcome trials will effect current treatment paradigms. FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING, SEPTEMBER 2016 WHAT MECHANISMS MIGHT EXPLAIN THE RAPID EFFECT ON MORTALITY SEEN IN THE...
Antonio Ceriello discusses the possible mechanisms explaining the results of the recent outcome trials. FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING, SEPTEMBER 2016 THE FINDINGS OF THE CARDIOVASCULAR OUTCOME TRIALS WERE DISAPPOINTING IN TERMS OF DPP-4...
Is high caloric intake the problem? Chip Lavie argues that fitness is far more important than fatness when it comes to overall health. Carl J. Lavie, M.D. Professor of Medicine and Medical Director of Cardiac Rehabilitation and Preventative Cardiology, the John Ochsner Heart and Vascular...
BREAKING NEWS: Oral medications can help people with type 2 diabetes reach their blood glucose targets. But there has been a cloud of suspicion over new diabetes drugs and whether they may increase the risk for cardiovascular and other problems. Today we heard the results of studies that looked at...
A new study from The University of Texas Medical Branch at Galveston of more than 30,000 commercially insured men is the first large comparative analysis to show that there is no link between testosterone therapy and blood clots in veins. The study found that middle-aged and older men who receive...

LATEST TWEETS

Conference Highlights